BHVN - Biohaven Ltd.

Day 1m 10m 60m PreMarket Market AfterHours Gap
16.68 0.69 (4.14%) --- --- --- -0.02 (-0.12%) 0.76 (4.57%) 0.01 (0.06%) 0.01 (0.06%)

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-1.94
Diluted EPS:
-1.94
Basic P/E:
-8.9536
Diluted P/E:
-8.9536
RSI(14) 1m:
0.0
VWAP:
17.37
RVol:
1.0025

Events

Period Kind Movement Occurred At
1m Price increase 1m 17.78 +0.41 (+2.36%) Oct 15 11:56
1m Price increase 1m 17.27 +0.29 (+1.71%) Oct 15 09:44

Related News